Literature DB >> 9649502

Suppression of the p300-dependent mdm2 negative-feedback loop induces the p53 apoptotic function.

A Thomas1, E White.   

Abstract

The p53 tumor suppressor gene product interacts with the p300 transcriptional coactivator that regulates the transactivation of p53-inducible genes. The adenovirus E1A protein has been shown to bind to p300 and inhibit its function. E1A inhibits p53 transactivation and also promotes p53 accumulation by a p300-dependent mechanism. Murine double minute 2 (Mdm2) is a transcriptional target of p53 that binds to p53 and inhibits its transcriptional activity. E1A inhibited mdm2 transactivation without affecting the expression of p21(WAF1) or Bax, which resulted in high levels of p53 accumulation and apoptosis. Ectopic expression of p300 restored Mdm2 levels and inhibited p53-dependent apoptosis, as did ectopic expression of Mdm2. Thus, p300 is required for mdm2 induction by p53 and the subsequent inhibition of p53 stabilization. Inhibition of p300 by E1A results in stabilization of p53 and causes apoptosis. Moreover, E1B 19K or Bcl-2 expression in E1A-transformed cells abrogated p53-dependent apoptosis by restoring mdm2 transactivation by p53. Hence, p300 regulation of mdm2 expression controls apoptotic activity of p53, and 19K or Bcl-2 bypass E1A inhibition of p300 transactivation of Mdm2.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9649502      PMCID: PMC316960          DOI: 10.1101/gad.12.13.1975

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  68 in total

1.  Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins.

Authors:  E White; R Cipriani; P Sabbatini; A Denton
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

2.  Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor.

Authors:  R Eckner; M E Ewen; D Newsome; M Gerdes; J A DeCaprio; J B Lawrence; D M Livingston
Journal:  Genes Dev       Date:  1994-04-15       Impact factor: 11.361

3.  Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product.

Authors:  P Whyte; K J Buchkovich; J M Horowitz; S H Friend; M Raybuck; R A Weinberg; E Harlow
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

4.  Adenovirus transforming 19-kD T antigen has an enhancer-dependent trans-activation function and relieves enhancer repression mediated by viral and cellular genes.

Authors:  K Yoshida; L Venkatesh; M Kuppuswamy; G Chinnadurai
Journal:  Genes Dev       Date:  1987-09       Impact factor: 11.361

5.  Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein.

Authors:  P Sabbatini; S K Chiou; L Rao; E White
Journal:  Mol Cell Biol       Date:  1995-02       Impact factor: 4.272

6.  Relief of p53-mediated transcriptional repression by the adenovirus E1B 19-kDa protein or the cellular Bcl-2 protein.

Authors:  Y Shen; T Shenk
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

7.  Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells.

Authors:  S K Chiou; C C Tseng; L Rao; E White
Journal:  J Virol       Date:  1994-10       Impact factor: 5.103

8.  CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein.

Authors:  D M Scolnick; N H Chehab; E S Stavridi; M C Lien; L Caruso; E Moran; S L Berger; T D Halazonetis
Journal:  Cancer Res       Date:  1997-09-01       Impact factor: 12.701

9.  p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60.

Authors:  C J Thut; J L Chen; R Klemm; R Tjian
Journal:  Science       Date:  1995-01-06       Impact factor: 47.728

10.  Cyclin G is a transcriptional target of the p53 tumor suppressor protein.

Authors:  K Okamoto; D Beach
Journal:  EMBO J       Date:  1994-10-17       Impact factor: 11.598

View more
  10 in total

Review 1.  Molecular interaction map of the mammalian cell cycle control and DNA repair systems.

Authors:  K W Kohn
Journal:  Mol Biol Cell       Date:  1999-08       Impact factor: 4.138

Review 2.  Mdm2: the ups and downs.

Authors:  T Juven-Gershon; M Oren
Journal:  Mol Med       Date:  1999-02       Impact factor: 6.354

3.  Critical role for Ser20 of human p53 in the negative regulation of p53 by Mdm2.

Authors:  T Unger; T Juven-Gershon; E Moallem; M Berger; R Vogt Sionov; G Lozano; M Oren; Y Haupt
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

4.  MicroRNA-221 regulates chondrogenic differentiation through promoting proteosomal degradation of slug by targeting Mdm2.

Authors:  Dongkyun Kim; Jinsoo Song; Eun-Jung Jin
Journal:  J Biol Chem       Date:  2010-06-24       Impact factor: 5.157

5.  Identification of three functions of the adenovirus e4orf6 protein that mediate p53 degradation by the E4orf6-E1B55K complex.

Authors:  E Querido; M R Morrison; H Chu-Pham-Dang; S W Thirlwell; D Boivin; P E Branton; M R Morisson
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

6.  Btf, a novel death-promoting transcriptional repressor that interacts with Bcl-2-related proteins.

Authors:  G M Kasof; L Goyal; E White
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

7.  Defect in the p53-Mdm2 autoregulatory loop resulting from inactivation of TAF(II)250 in cell cycle mutant tsBN462 cells.

Authors:  C Wasylyk; B Wasylyk
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

8.  p300 regulates p53-dependent apoptosis after DNA damage in colorectal cancer cells by modulation of PUMA/p21 levels.

Authors:  N Gopalakrishna Iyer; Suet-Feung Chin; Hilal Ozdag; Yataro Daigo; De-En Hu; Massimiliano Cariati; Kevin Brindle; Samuel Aparicio; Carlos Caldas
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-27       Impact factor: 11.205

9.  Ash2L enables P53-dependent apoptosis by favoring stable transcription pre-initiation complex formation on its pro-apoptotic target promoters.

Authors:  S K Mungamuri; S Wang; J J Manfredi; W Gu; S A Aaronson
Journal:  Oncogene       Date:  2014-07-14       Impact factor: 9.867

Review 10.  Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene Therapy.

Authors:  Christian Bressy; Eric Hastie; Valery Z Grdzelishvili
Journal:  Mol Ther Oncolytics       Date:  2017-03-21       Impact factor: 7.200

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.